
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50
Xiang Ao, Wei Ding, Xiaoge Li, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 501-526
Closed Access | Times Cited: 50
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Ying Liu, Wei Ding, Jianxun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114993-114993
Open Access | Times Cited: 50
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
The applications of nanozymes in cancer therapy: based on regulating pyroptosis, ferroptosis and autophagy of tumor cells
Yuan Zhang, Wanpeng Yu, Mengmeng Chen, et al.
Nanoscale (2023) Vol. 15, Iss. 29, pp. 12137-12156
Closed Access | Times Cited: 33
Yuan Zhang, Wanpeng Yu, Mengmeng Chen, et al.
Nanoscale (2023) Vol. 15, Iss. 29, pp. 12137-12156
Closed Access | Times Cited: 33
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 22
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 22
NF‐κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation
Mohammad Yasin Zamanian, Hashem O. Alsaab, Maryam Golmohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 13
Mohammad Yasin Zamanian, Hashem O. Alsaab, Maryam Golmohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 13
Programmed cell death in tumor immunity: mechanistic insights and clinical implications
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications
Zhongyu Wang, Zeng-Jin Wen, Hai-Ming Xu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 35
Zhongyu Wang, Zeng-Jin Wen, Hai-Ming Xu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 35
CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis
Lei Zhang, Yuan Zhang, Xin Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Lei Zhang, Yuan Zhang, Xin Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei‐ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 17
Mei‐ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 17
Baizhu shaoyao decoction restores the intestinal barrier and brain–gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1/FoxO3a
Yuanyuan Wei, Yimeng Fan, Sijuan Huang, et al.
Phytomedicine (2023) Vol. 122, pp. 155163-155163
Closed Access | Times Cited: 17
Yuanyuan Wei, Yimeng Fan, Sijuan Huang, et al.
Phytomedicine (2023) Vol. 122, pp. 155163-155163
Closed Access | Times Cited: 17
Visualizing cancer resistance via nano-quenching and recovery detector of CD44
Jialin Zeng, Li-Hua Yang, Lingke Zeng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jialin Zeng, Li-Hua Yang, Lingke Zeng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Yuxiang Li, Jing Bai, Dan Liu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
The dual missions of FoxO3a in inflammatory diseases: Regulation of antioxidant enzymes and involvement in programmed cell death
Xiangli Ma, Yujie Lin, Ling Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114369-114369
Closed Access
Xiangli Ma, Yujie Lin, Ling Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114369-114369
Closed Access
Structural and Functional Insights into Targeting GCCG Sites in the EGFR Promoter by Two DNA Intercalators to Inhibit Breast Cancer Metastasis
Chih-Chun Chang, Hsin‐Ju Li, Roshan Satange, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Chih-Chun Chang, Hsin‐Ju Li, Roshan Satange, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
FADD as a key molecular player in cancer progression
Ying Liu, Xiaoge Li, Xuehao Zhou, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Ying Liu, Xiaoge Li, Xuehao Zhou, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Copper and Diabetes: Current Research and Prospect
Wenguang Chang, Peifeng Li
Molecular Nutrition & Food Research (2023) Vol. 67, Iss. 23
Open Access | Times Cited: 14
Wenguang Chang, Peifeng Li
Molecular Nutrition & Food Research (2023) Vol. 67, Iss. 23
Open Access | Times Cited: 14
Role and regulation of FOXO3a: new insights into breast cancer therapy
Wenqiu Mei, Bingyin Mei, Jing Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Wenqiu Mei, Bingyin Mei, Jing Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression
Ying Liu, Yiwen Li, Chengcheng Du, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 11, pp. 1539-1556
Closed Access | Times Cited: 21
Ying Liu, Yiwen Li, Chengcheng Du, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 11, pp. 1539-1556
Closed Access | Times Cited: 21
The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes
Man Wang, Lei Zhang, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Man Wang, Lei Zhang, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Unique regulatory roles of ncRNAs changed by PM2.5 in human diseases
Bo He, Hai-Ming Xu, Haowen Liu, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 255, pp. 114812-114812
Open Access | Times Cited: 10
Bo He, Hai-Ming Xu, Haowen Liu, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 255, pp. 114812-114812
Open Access | Times Cited: 10
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway
Yizhe Cheng, Ping Zhan, Jing Lü, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1577-1592
Closed Access | Times Cited: 10
Yizhe Cheng, Ping Zhan, Jing Lü, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1577-1592
Closed Access | Times Cited: 10
The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review)
Lei Zhang, Huijuan Gao, Xin Li, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 2
Open Access | Times Cited: 10
Lei Zhang, Huijuan Gao, Xin Li, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 2
Open Access | Times Cited: 10
Interplay between Gut Microbiota and NLRP3 Inflammasome in Intracerebral Hemorrhage
Yuan Zhang, Wanpeng Yu, Christopher Flynn, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5251-5251
Open Access | Times Cited: 17
Yuan Zhang, Wanpeng Yu, Christopher Flynn, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5251-5251
Open Access | Times Cited: 17